world_health_organization_flag

WHO aims to increase uptake of biosimilars in poorer countries

May 4, 2017
Medical Communications, Research and Development Cancer, Roche, WHO, biosimilars

The WHO has announced that it will launch a project to prequalify biosimilar medicines for the treatment of certain cancers. …

roche

Roche denies its acne treatment led to suicide of 21 year old

May 4, 2017
Medical Communications, Sales and Marketing Roaccutane, Roche

Last month, Luke Reeves took his own life at the age of just 21. Prior to his death, he had …

blood-1813410_960_720

Cheap blood test may help tailor prostate cancer treatment

May 4, 2017
Research and Development Blood test, prostate cancer

A blood test that costs less than £50 to perform could prevent men from undergoing treatment with two drugs that …

shutterstock_243110086

Real-world data: High on the life science agenda

May 3, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing real world data, real-world data

John Wise of The Pistoia Alliance discusses the necessity of real-world data for a prosperous future for the life sciences …

shutterstock_159488225

Researchers identify key trigger in melanoma progression

May 3, 2017
Research and Development melanoma

Researchers from life sciences research institute VIB and KU Leuven in Belgium in collaboration with INSERM, the French National Institute …

shutterstock_141299494

Study discovers origin of cancer metastases and why they reoccur

May 3, 2017
Research and Development Cancer, metastases

A team of scientists from The Scripps Research Institute (TSRI) have discovered the secrets of where metastases originate and why …

ketmine_injection_i

First large-scale study gives hope for ketamine as a depression therapy

May 3, 2017
Research and Development Ketamine, depression, mental health

While the development of truly innovative mental health therapies has ground to a halt somewhat, scientific research in the field …

NICE recommends Janssen’s first-of-its-kind Crohn’s drug Stelara

May 3, 2017
Research and Development, Sales and Marketing Crohn’s disease, Janssen, NICE, Stelara, crohn's disease

Janssen has announced that it has secured recommendation from NICE for Stelara (ustekinumab) in the indication of moderately to severely …

imeche-logo

UK must prioritise $17bn medtech sector in face of Brexit, new report urges

May 3, 2017
Manufacturing and Production, Research and Development, Sales and Marketing Institution of Mechanical Engineers, brexit, general election, medtech

A new report from the Institution of Mechanical Engineers (IME) has highlighted the threat Brexit poses to the $17 billion …

bia

BioIndustry Association calls for governmental support ahead of UK general election

May 2, 2017
Manufacturing and Production, Sales and Marketing BIA, general election

In the run-up to the UK’s general election in June, government spending within the life sciences industry has become a …

astrazeneca_sign_sky

Potential blockbuster AZ immunotherapy secures FDA approval

May 2, 2017
Manufacturing and Production, Sales and Marketing AstraZeneca, bladder cancer, darzalex

The FDA has granted accelerated approval to AstraZeneca’s (AZ) immunotherapy therapy Imfinzi (durvalumab) for the treatment of locally advanced or …

mouse

Researchers control blood sugar levels in mice via smartphone app

May 2, 2017
Manufacturing and Production, Research and Development diabetes

Scientists at Shanghai’s East China Normal University have been able to regulate blood sugar levels in mice via the use …

janssen_latest_logo_on_sign

Janssen scores EU approval for blood cancer drug Darzalex

May 2, 2017
Manufacturing and Production, Sales and Marketing Europe, European Commission, Janssen, darzalex

Janssen has announced that its CD38-directed monoclonal antibody Darzalex (daratumumab) has expanded its indication with a thumbs-up from the European …

shire_image

Shire creates 150 jobs with Dublin HQ relocation

May 2, 2017
Manufacturing and Production Dublin, Shire

Rare disease specialist Shire has opened the doors of its new headquarters in Dublin, Ireland. The pharma company has leased …

scott_gottlieb

Scott Gottlieb enters final stage of approval for FDA Commissioner role

April 28, 2017
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FDA, Trump, scotrt gottlieb

Trump’s pick for the top job in the FDA moved one step closer to taking up the job when the …

pills_spill

Cancer Drug Fund roundly criticised as ‘wastage of resources’

April 28, 2017
Medical Communications Cancer Drug Fund, Conservative, NHS, NICE, UK

The Cancer Drug Fund (CDF), which has now been absorbed into NICE, previous methods of funding have been fiercely criticised …

4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

April 28, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten

In response to the announcement of a UK snap election, this week saw the release of the ABPI’s 2017 General …

bayer_cross_2

FDA approves first new drug for liver cancer in decade

April 28, 2017
Medical Communications, Sales and Marketing Bayer, Stivarga, hepatocellular carcinoma, liver cancer

The FDA has announced that it has approved the first new treatment for hepatocellular carcinoma (HCC), a type of liver …

733px-reduction_gear

The five competencies of continuous regulatory compliance

April 28, 2017
Medical Communications pharmafile, regulatory compliance

Look at any country or region with a strong generic pharmaceutical and active ingredient manufacturing sector, and you are sure …

thorkil_kastberg_christensen_provided_photo

SAB Biotherapeutics moves to bolster board

April 27, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

SAB Biotherapeutics, a clinical-stage biopharmaceutical development company, announced that it had appointed Thorkil Kastberg Christensen to its Board of Directors. …

The Gateway to Local Adoption Series

Latest content